GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) » Definitions » Book Value per Share

Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Book Value per Share : ¥6.02 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Suzhou Zelgen Biopharmaceuticals Co Book Value per Share?

Suzhou Zelgen Biopharmaceuticals Co's book value per share for the quarter that ended in Mar. 2024 was ¥6.02.

During the past 12 months, Suzhou Zelgen Biopharmaceuticals Co's average Book Value Per Share Growth Rate was 124.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -2.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 92.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Suzhou Zelgen Biopharmaceuticals Co was 450.10% per year. The lowest was -2.90% per year. And the median was 58.30% per year.

Suzhou Zelgen Biopharmaceuticals Co's current price is ¥56.00. Its book value per share for the quarter that ended in Mar. 2024 was ¥6.02. Hence, today's PB Ratio of Suzhou Zelgen Biopharmaceuticals Co is 9.30.

During the past 8 years, the highest P/B Ratio of Suzhou Zelgen Biopharmaceuticals Co was 22.21. The lowest was 5.79. And the median was 9.52.


Suzhou Zelgen Biopharmaceuticals Co Book Value per Share Historical Data

The historical data trend for Suzhou Zelgen Biopharmaceuticals Co's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Zelgen Biopharmaceuticals Co Book Value per Share Chart

Suzhou Zelgen Biopharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial 0.02 6.74 4.99 3.16 6.17

Suzhou Zelgen Biopharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.68 6.87 6.54 6.17 6.02

Competitive Comparison of Suzhou Zelgen Biopharmaceuticals Co's Book Value per Share

For the Biotechnology subindustry, Suzhou Zelgen Biopharmaceuticals Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Zelgen Biopharmaceuticals Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Zelgen Biopharmaceuticals Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Suzhou Zelgen Biopharmaceuticals Co's PB Ratio falls into.



Suzhou Zelgen Biopharmaceuticals Co Book Value per Share Calculation

Suzhou Zelgen Biopharmaceuticals Co's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1,632.9-0.0)/264.7
=6.17

Suzhou Zelgen Biopharmaceuticals Co's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1,593.7-0.0)/264.7
=6.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Suzhou Zelgen Biopharmaceuticals Co  (SHSE:688266) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Suzhou Zelgen Biopharmaceuticals Co Book Value per Share Related Terms

Thank you for viewing the detailed overview of Suzhou Zelgen Biopharmaceuticals Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Business Description

Traded in Other Exchanges
N/A
Address
No.209 Chenfeng Road, Yushan Town, Jiangsu Province, Kunshan, CHN
Suzhou Zelgen Biopharmaceuticals Co Ltd is engaged in research and development of new chemical and biological drugs for various therapeutic areas, including tumors, bleeding and blood diseases, and hepatobiliary diseases.
Executives
Zhang Bin Core technical personnel
Huang Gang senior management
Lv Bin Hua Directors, senior managers, core technical personn
Lu Hui Ping Directors, senior managers
Gao Qing Ping senior management
Wu Ji Sheng Directors, senior managers, core technical personn
Zhang Jun Li senior management
Wu Li Qing Core technical personnel
Core technical personnel
Sheng Ze Lin Directors, senior managers, core technical personn

Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Headlines

No Headlines